Optimized Oxygen Delivery During General Anesthesia in Newborn Infants
NCT ID: NCT02698020
Last Updated: 2018-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2015-11-30
2018-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation
NCT02040909
Changes in Tissue and Cerebral Oxygenation Following Spinal Anesthesia in Neonates, Infants, and Children
NCT02840253
Influence of Premedication Protocols for Neonatal Endotracheal Intubation on Cerebral Oxygenation
NCT01427985
Codeine in Mechanically Ventilated Neonates
NCT01322204
Regulated Expiratory Breathing Method During Childbirth
NCT04219631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
High level of supplemental inspired oxygen
No interventions assigned to this group
Room-air
Supplemental oxygen only provided if oxygen saturation below target
Room-air
Provision of room-air
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Room-air
Provision of room-air
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No pulmonary disease, no oxygen requirement, or assisted ventilation
3. No genetic syndrome
4 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uppsala University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Agren, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Women's and Children's Health, Uppsala University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uppsala University Hospital, Pediatric anesthesia Unit
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANOXneo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.